Dennis T. Ko, M.D. However, a significant proportion of STEMI patients will "fail" to reperfuse following fibrinolytic therapy; indeed, normal coronary blood flow (TIMI flow grade 3) is achieved in ...
Researchers found that in vitro clot formulation and fibrinolysis assays were able to determine the hemostatic effects of different replacement agents, as well as identify distinct pharmacodynamic ...
Methylation profiling of locally advanced rectal cancer (LARC): Exploration of potential predictive markers for neoadjuvant chemoradiation (NACR). This is an ASCO Meeting Abstract from the 2017 ...
In a randomized, double-blind trial, we compared tenecteplase plus heparin with placebo plus heparin in normotensive patients with intermediate-risk pulmonary embolism. Eligible patients had right ...
Fibrinolysis is the break-down of blood clots, which is a crucial part of wound healing. If fibrinolysis is not properly regulated it can lead to numerous different diseases. A blood clot (Thrombus) ...
SAN FRANCISCO, CA—Prehospital fibrinolysis with timely coronary angiography results in equally effective reperfusion compared with primary percutaneous coronary intervention (PCI) in patients ...
The intention-to-treat population comprised 544 patients: 273 in the intervention group and 271 in the control group. The mean (±SD) age was 58.2±13.5 years, and 42.6% of the patients were women. A ...
PARIS, France—Sending patients with STEMI to invasive centers for primary PCI rather than keeping them and administering fibrinolytics has had long-lasting clinical benefits, extended follow-up of the ...
When injured, endothelial cells permit granulocytes and plasma constituents to enter inflamed tissue, which may lead to organ damage. Endothelial cell inflammation causes vasodilation through the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results